Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
基本信息
- 批准号:10507783
- 负责人:
- 金额:$ 41.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-11-22 至 2024-10-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAblationBindingBinding ProteinsBinding SitesCD8B1 geneCell LineageCell ProliferationCellsChromatinChromatin StructureComplexDNADNA BindingDNA Binding DomainDNA SequenceDNA-Binding ProteinsDataDevelopmentDevelopmental ProcessDifferentiated GeneDiseaseE-Box ElementsEnhancersEpigenetic ProcessEukaryotaEventFamilyGene ActivationGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGoalsImmuneImmunityIndividualInternetKnowledgeLengthLiteratureMediatingMolecularMolecular ConformationMusMutateNuclearOutcomeProcessPromoter RegionsProtein IsoformsProteinsRegulationRegulatory ElementResearchRoleSeriesShapesSiteT cell differentiationT cell transcription factor 1T-Cell DevelopmentT-LymphocyteTestingTherapeutic InterventionThymocyte DevelopmentThymus GlandTissuesbeta catenincdc Genesgene repressiongenetic regulatory proteingenome-widelymphoid enhancer-binding factor 1membermolecular modelingnovelprogramspromoterprotein complexrecruitthymocyte
项目摘要
PROJECT SUMMARY
Thymic development is highly responsible for shaping a healthy and balanced T cell immunity. Like other
developmental processes it involves coordinated changes in the linear and three-dimensional chromatin
organization that allow stage specific transcription events. A central regulator at nearly every stage of T cell
differentiation is the DNA binding protein Tcf-1. Studies proposed here will elucidate how Tcf-1 coordinates the
action of epigenetic and transcription regulators to instruct the differentiation of CD4+CD8+ DP thymocytes. Tcf-
1 modulates the chromatin landscapes and transcription profiles directly through binding to its conserved DNA
sequence, or indirectly in association with other regulatory proteins. DP thymocytes express two forms of Tcf-
1, the full length Tcf-1p45 protein that binds β-catenin, and a short Tcf-1p38 isoform that does not. Lef-1, another
member of the Tcf/Lef family of regulators, also expressed in thymocytes has overlapping functions with Tcf-1.
In addition Tcf-1 cooperates with the HLH domain DNA binding protein HEB at the DP thymocyte stages
through the sharing of ~7000 DNA binding sites genome wide. The presence of both Tcf-1 and HEB at the
shared sites is necessary to promote chromatin accessibility and regulate gene transcription. The direct Tcf-1-
HEB binding to their conserved motifs in enhancer regions of T cell differentiation genes promotes their
expression. By contrast Tcf-1-HEB recruitment to sites lacking conserved motifs, in promoter regions of cell-
cycle genes reduces their expression and cell proliferation. Such opposing transcription outcomes likely involve
Tcf-1-HEB recruitment to DNA in the context of distinct regulatory complexes. The composition of complexes
containing Tcf-1 and HEB, the specific Tcf-1 isoform involved in each complex, and which functions are
redundant between Tcf-1 and Lef-1, still remain to be elucidated. The intricate functional co-operation between
these factors likely also involves the ability of Tcf-1 and Lef-1 to bend the DNA helix at their binding site which
may modulate the 3D chromatin conformation, and define the proximity between co-operating factors and
regulatory elements. These findings and the existing literature provide strong premise for the hypothesis that
DP thymocyte development is enabled by the cooperation of Tcf-1 isoforms with protein complexes that shape
the 3D chromatin structure to differentially regulate gene expression. Two specific aims are proposed. Aim 1
will determine the how Tcf-1p45 and, Tcf-1p33, co-operate with Lef-1 and HEB in the context of distinct regulatory
complexes to establish the epigenetic and transcription profile of DP thymocytes and control their
developmental progression. Aim 2: will elucidate the roles of Tcf-1p45, Tcf-1p33, Lef-1 with HEB shaping the
chromatin conformation, and how this function promotes DP thymocyte development. The proposed studies
are expected to highlight a completely new layer in the molecular regulation of DP thymocytes.
项目摘要
胸腺发育高度负责塑造健康且平衡的T细胞免疫。像其他
发育过程涉及线性和三维染色质的协调变化
允许阶段特定转录事件的组织。几乎每个T细胞阶段的中央调节器
分化是DNA结合蛋白TCF-1。这里提出的研究将阐明TCF-1如何坐标
表观遗传和转录调节剂的作用指导CD4+ CD8+ DP胸腺细胞的分化。 tcf-
1通过与其配置的DNA结合直接调节染色质景观和转录曲线
序列,或间接与其他调节蛋白相关。 DP胸腺细胞表达两种形式的TCF-
1,结合β-catenin的全长TCF-1P45蛋白,而没有的短TCF-1P38同工型。 LEF-1,另一个
TCF/LEF调节剂家族的成员也表达在胸腺细胞中,其功能与TCF-1重叠。
另外,TCF-1与HLH结构域DNA结合蛋白HEB在DP胸腺细胞阶段合作
通过共享约7000个DNA结合位点基因组宽。 TCF-1和HEB的存在
共享位点对于促进染色质的可及性和调节基因转录是必要的。直接的TCF-1-
HEB与T细胞分化基因增强子区域中其配置的基序结合促进
表达。相比之下,在细胞的启动子区域中,TCF-1-HEB招募缺乏构成基序的地点
循环基因降低其表达和细胞增殖。这种相反的转录结果可能涉及
在不同的调节复合物的背景下,TCF-1-HEB募集到DNA。复合物的组成
包含TCF-1和HEB,每个复合物涉及的特定TCF-1同工型,哪些功能是
TCF-1和LEF-1之间的冗余仍然有待阐明。复杂的功能合作
这些因素可能还涉及TCF-1和LEF-1在其结合位点弯曲DNA螺旋的能力,该位点的能力
可能调节3D染色质构象,并定义合作因素和
监管要素。这些发现和现有文献为以下假设提供了有力的前提。
DP胸腺细胞发育是通过与蛋白质复合物合作的合作
3D染色质结构对不同的调节基因表达。提出了两个具体目标。目标1
将在不同调节的情况下确定如何与LEF-1和HEB合作的TCF-1P45和TCF-1P33
建立DP胸腺细胞的表观遗传和转录谱的复合物并控制其
发展进展。 AIM 2:将阐明TCF-1P45,TCF-1P33,LEF-1的角色,HEB塑造
染色质构象以及该功能如何促进DP胸腺细胞发育。提出的研究
预计将在DP胸腺细胞的分子调节中突出一个全新的层。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fotini Gounari其他文献
Fotini Gounari的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fotini Gounari', 18)}}的其他基金
Tools for reversible short-term degradation of TCF-1 to address its molecular functions
用于 TCF-1 可逆短期降解以解决其分子功能的工具
- 批准号:
10647571 - 财政年份:2023
- 资助金额:
$ 41.5万 - 项目类别:
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal
β-连环蛋白如何扩增 Foxp3 RORgammat 促炎 T 调节细胞 - 更新
- 批准号:
10685078 - 财政年份:2022
- 资助金额:
$ 41.5万 - 项目类别:
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal
β-连环蛋白如何扩增 Foxp3 RORgammat 促炎 T 调节细胞 - 更新
- 批准号:
10698144 - 财政年份:2022
- 资助金额:
$ 41.5万 - 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
- 批准号:
10488196 - 财政年份:2021
- 资助金额:
$ 41.5万 - 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
- 批准号:
10296060 - 财政年份:2021
- 资助金额:
$ 41.5万 - 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
- 批准号:
9917226 - 财政年份:2019
- 资助金额:
$ 41.5万 - 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
- 批准号:
10617463 - 财政年份:2019
- 资助金额:
$ 41.5万 - 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
- 批准号:
10061551 - 财政年份:2019
- 资助金额:
$ 41.5万 - 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
- 批准号:
10287489 - 财政年份:2019
- 资助金额:
$ 41.5万 - 项目类别:
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatory T-regulatory cells
β-连环蛋白如何扩增 Foxp3 RORgammat 促炎性 T 调节细胞
- 批准号:
10203822 - 财政年份:2015
- 资助金额:
$ 41.5万 - 项目类别:
相似国自然基金
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
- 批准号:62372469
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
- 批准号:82373219
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
- 批准号:32300701
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
- 批准号:82302332
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of meningeal lymphatic vasculature in neuroimmune communication development
脑膜淋巴管系统在神经免疫通讯发育中的作用
- 批准号:
10566682 - 财政年份:2023
- 资助金额:
$ 41.5万 - 项目类别:
Engineering the Next Generation of Safer Hsp90 Inhibitors
设计下一代更安全的 Hsp90 抑制剂
- 批准号:
10587304 - 财政年份:2023
- 资助金额:
$ 41.5万 - 项目类别:
Genome organizer SATB1 function in salivary gland and development and growth
基因组组织者 SATB1 在唾液腺及其发育和生长中的功能
- 批准号:
10593721 - 财政年份:2023
- 资助金额:
$ 41.5万 - 项目类别:
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma
TAZ 和 YAP 在 3D 基因组组织 DNA 损伤修复中的新作用以及胶质母细胞瘤的治疗耐药性
- 批准号:
10649830 - 财政年份:2023
- 资助金额:
$ 41.5万 - 项目类别:
Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated Neurotoxicity
CAR T 细胞治疗相关神经毒性中的内皮-白细胞粘附
- 批准号:
10735681 - 财政年份:2023
- 资助金额:
$ 41.5万 - 项目类别: